2020年9月14日~9月20日の間に収集した論文情報を追加しました。(1/2)
①Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system.
DPP-4阻害薬の有害事象プロファイル
対象DB:FAERS
②BCR-ABL Tyrosine Kinase Inhibitor-associated Thyroid Dysfunction: A Review of Cases Reported to the FDA Adverse Event Reporting System and Published in the Literature.
BCR-ABLチロシンキナーゼ阻害剤関連甲状腺機能不全の研究、症例レビュー
③Glucagon-like peptide-1 analogues and thyroid cancer: An analysis of cases reported in the European pharmacovigilance database.
糖尿病患者のGLP-1アナログ治療中の甲状腺がんシグナル検出研究
対象DB:EudraVigilance
④An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
ジンバブエのファーマコビジランス報告傾向と特性の特定研究
対象DB:VigiBase
⑤Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan.
L-AMB投与腎不全患者における急性腎障害に関連する要因特定研究
対象DB:DPC
⑥Trends in arthroplasty in Japan by a complete survey, 2014-2017.
関節形成術(膝、腰、肩、指、肘、足/足首)傾向調査
対象DB:NDB
⑦Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis.
潰瘍性大腸炎における医療リソース利用と術後ケア医療費評価研究
対象DB:CPRD
Date
(PubMed追加日)